How common is fluoroquinolone resistance in community-acquired E. coli causing urinary tract infections in Mexico?
Fluoroquinolone resistance in E. coli causing urinary tract infections (UTIs) is a growing concern globally, with significant variation across regions. In Mexico, research indicates that resistance is particularly high among community-acquired isolates. This is especially true for strains that produce extended-spectrum beta-lactamase (ESBL), which are often linked to fluoroquinolone resistance.
What the research says
A global meta-analysis found that the overall pooled prevalence of fluoroquinolone resistance in E. coli causing UTIs is approximately 31%, with higher rates observed in developing countries compared to developed ones 16. In Mexico specifically, a study analyzing community-acquired E. coli isolates found that 68% were ESBL-producing, and these strains showed high rates of fluoroquinolone resistance 3.
What to ask your doctor
- What is the current resistance rate of fluoroquinolones in E. coli causing UTIs in my region?
- Are ESBL-producing strains common in my area, and how does this affect my treatment options?
- What are the recommended first-line antibiotics for uncomplicated UTIs in my community?
- Should I request a urine culture before starting antibiotic treatment for a UTI?
This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.